An Exploratory Clinical Study of Adebrelimab Maintenance Treatment Following Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Adebrelimab (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 24 Jan 2025 New trial record